1例β-内酰胺类抗菌药物致中性粒细胞减少的病例分析
2016-06-03金知萍蔡映云陈璋璋
金知萍+蔡映云+陈璋璋
摘 要 1例54岁中年男性因“社区获得性肺炎”接受β-内酰胺类药物治疗3周后,呼吸道症状好转,同时出现中性粒细胞减少。药师考虑与治疗药物相关可能大,建议停止抗感染治疗。患者停药12 d后未经治疗中性粒细胞计数恢复正常,可以确诊为药源性中性粒细胞减少。
关键词 中性粒细胞减少 药源性 β-内酰胺类药物 药物不良反应
中图分类号:R978.11; R563.11 文献标识码:C 文章编号:1006-1533(2016)09-0062-03
Analysis of one case of neutrophil deficiency induced by β-lactams
JIN Zhiping1*, CAI Yingyun2, CHEN Zhangzhang1**
(1. Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China;
2. Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200032, China)
ABSTRACT A 54 years old man diagnosed as community acquired pneumonia got agranulocytosis after 3-week treatment of β-lactams. The clinical pharmacist regarded it as drug-induced agranulocytosis and suggested to stop anti-infection treatment. The absolute neutrophil count of the patient returned to normal 12 days after the withdrawal of β-lactams without any special treatment. It was a confirmed case of drug-induced agranulocytosis.
KEY WORDS agranulocytosis; drug-induced; b-lactams; adverse drug reaction
患者在接受抗感染治疗一段时间后,出现中性粒细胞减少的情况临床上并不少见。及时判断中性粒细胞减少与感染相关还是与药物使用相关尤为重要。如果患者的中性粒细胞减少与药物相关而非感染本身,那么加大抗感染治疗力度不但于疾病无益,反而会造成严重的不良后果。以下通过对1例β-内酰胺类抗菌药物致中性粒细胞减少的病例进行分析,为临床药师及时判断和处理此类药物不良反应提供参考。
1 病史摘要
患者,男性,54岁,因“咳嗽咳痰1月余”入院。
患者1个月前无明显诱因出现咳嗽,以干咳为主,少量白色黏痰,不易咳出,无脓臭痰及铁锈色痰,无午后低热、盗汗、咯血,无畏寒高热,无胸痛胸闷。患者未予重视,自行服用枇杷露和头孢克洛胶囊(具体用法用量不详),用药1周余,症状控制不佳。后至上海某医院,查胸部CT示:右肺中叶外侧段炎症伴实变,右肺中叶及左肺下叶散在钙化灶;左肺上叶舌段及下叶纤维化。血常规示:白细胞计数5.34×109/L,中性粒细胞计数3.25×109/L,中性粒细胞百分比60.9%。……
